<DOC>
	<DOC>NCT03052283</DOC>
	<brief_summary>Development, validation and evaluation of a new multimodal questionnaire to assess and quantify the abdominal involvement in patients with the inherited life shortening multi-organ disease Cystic fibrosis.</brief_summary>
	<brief_title>Symptom Score to Assess Abdominal Involvement in Patients With Cystic Fibrosis</brief_title>
	<detailed_description>Development of a multimodal questionnaire considering the FDA guidelines for patient reported outcome measures (PROM) - Evaluation of reliability of the questionnaire by examining internal consistency and construct validity - Evaluation of reproducibility of the questionnaire by re-testing of patients - Assessment of cross-generational applicability of the questionnaire by sub-scoring of age groups - Evaluation of the responsiveness of the score by comparison with age-matched healthy controls - Assessment of putative relationships of abdominal symptoms with faecal inflammatory markers - Assessment of applicability of the questionnaire in other CF centers - Transfer the JenAbdomen Score to other countries and languages</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>CF cohort: Diagnosis of CF determined by a sweat chloride of &gt;60 mEq/L and/or detection of 2 disease causing CFTR mutations with evidence of organ involvement. Healthy controls: Agematched CF cohort: Lacking ability to cooperate of patients /their families, respectively Healthy controls: Other diseases causing abdominal symptoms (alpha 1 antitrypsin deficiency, celiac disease, food allergy, gastroenteritis, etc.)</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Cystic fibrosis</keyword>
	<keyword>Abdomen</keyword>
	<keyword>Pancreas</keyword>
	<keyword>Liver</keyword>
	<keyword>Gut</keyword>
	<keyword>Symptom Score</keyword>
	<keyword>Patient reported outcome measure (PROM)</keyword>
</DOC>